HK1198654A1 - Recombinant antibodies having dual specificity for gangliosides and use thereof - Google Patents

Recombinant antibodies having dual specificity for gangliosides and use thereof

Info

Publication number
HK1198654A1
HK1198654A1 HK14112117.7A HK14112117A HK1198654A1 HK 1198654 A1 HK1198654 A1 HK 1198654A1 HK 14112117 A HK14112117 A HK 14112117A HK 1198654 A1 HK1198654 A1 HK 1198654A1
Authority
HK
Hong Kong
Prior art keywords
gangliosides
recombinant antibodies
dual specificity
specificity
dual
Prior art date
Application number
HK14112117.7A
Other languages
English (en)
Chinese (zh)
Inventor
．莫利諾弗裡亞斯
．羅扎斯多蘭特斯
．卡撒德薩斯帕索斯
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48039960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1198654(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of HK1198654A1 publication Critical patent/HK1198654A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
    • C07K16/3084—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HK14112117.7A 2012-03-01 2014-12-02 Recombinant antibodies having dual specificity for gangliosides and use thereof HK1198654A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20120035A CU24120B1 (es) 2012-03-01 2012-03-01 Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
PCT/CU2013/000001 WO2013127373A2 (es) 2012-03-01 2013-02-21 Anticuerpos recombinantes con especificidad dual por gangliósidos y su uso

Publications (1)

Publication Number Publication Date
HK1198654A1 true HK1198654A1 (en) 2015-05-22

Family

ID=48039960

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112117.7A HK1198654A1 (en) 2012-03-01 2014-12-02 Recombinant antibodies having dual specificity for gangliosides and use thereof

Country Status (22)

Country Link
US (1) US9527920B2 (xx)
EP (1) EP2821417A2 (xx)
JP (1) JP5933044B2 (xx)
KR (1) KR20140126349A (xx)
CN (1) CN104136463B (xx)
AR (1) AR090207A1 (xx)
AU (1) AU2013225453A1 (xx)
CA (1) CA2865050A1 (xx)
CL (1) CL2014002236A1 (xx)
CO (1) CO7051011A2 (xx)
CU (1) CU24120B1 (xx)
EA (1) EA201491618A1 (xx)
HK (1) HK1198654A1 (xx)
IL (1) IL234394A0 (xx)
MX (1) MX2014010456A (xx)
PE (1) PE20142277A1 (xx)
PH (1) PH12014501950A1 (xx)
SG (1) SG11201405151YA (xx)
TN (1) TN2014000330A1 (xx)
TW (1) TW201348259A (xx)
WO (1) WO2013127373A2 (xx)
ZA (1) ZA201407043B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
EP3277713A1 (en) * 2015-03-31 2018-02-07 VHsquared Limited Polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4107154A1 (de) 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
CU22731A1 (es) 1998-02-05 2002-02-28 Centro Inmunologia Molecular Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen
CU23403A1 (es) * 2003-04-23 2009-08-04 Centro Inmunologia Molecular Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores
CU24120B1 (es) * 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3

Also Published As

Publication number Publication date
WO2013127373A3 (es) 2013-10-31
AU2013225453A1 (en) 2014-09-25
AR090207A1 (es) 2014-10-29
CU24120B1 (es) 2015-08-27
CN104136463A (zh) 2014-11-05
JP5933044B2 (ja) 2016-06-08
EP2821417A2 (en) 2015-01-07
CL2014002236A1 (es) 2014-12-05
ZA201407043B (en) 2015-12-23
WO2013127373A2 (es) 2013-09-06
US9527920B2 (en) 2016-12-27
CA2865050A1 (en) 2013-09-06
MX2014010456A (es) 2014-10-13
IL234394A0 (en) 2014-10-30
CU20120035A7 (es) 2013-10-29
PE20142277A1 (es) 2015-01-15
SG11201405151YA (en) 2014-10-30
US20150093385A1 (en) 2015-04-02
TW201348259A (zh) 2013-12-01
KR20140126349A (ko) 2014-10-30
JP2015516367A (ja) 2015-06-11
TN2014000330A1 (en) 2015-12-21
CO7051011A2 (es) 2014-09-10
PH12014501950A1 (en) 2014-11-24
EA201491618A1 (ru) 2014-12-30
CN104136463B (zh) 2016-08-24
EP2821417A9 (en) 2015-04-01

Similar Documents

Publication Publication Date Title
HK1216647A1 (zh) 治療性 抗體
HK1211302A1 (en) Asgpr antibodies and uses thereof asgpr
HK1207092A1 (en) Anti-hla-b27 antibodies and uses thereof -hla-b27
HK1201296A1 (en) Modified fc region of antibody fc
DK2729170T3 (en) Antibody variants and uses thereof
EP2776906A4 (en) TOUCH-DISPLAY DEVICE HAVING DOUBLE TOUCH PANEL
HRP20190358T1 (hr) Antitijela protiv asic1 i njihova primjena
SG11201407099WA (en) Anti-pcsk9 antibodies and use thereof
HK1207654A1 (en) Modified antibody regions and uses thereof
EP2832856A4 (en) ANTI-LAMP5 ANTIBODIES AND USE THEREOF
EP2830660A4 (en) ANTI-SEMA4D ANTIBODIES AND EPITOPES
EP2861623A4 (en) NEW SPECIFIC CLEC14A ANTIBODY AND USES THEREOF
HK1198654A1 (en) Recombinant antibodies having dual specificity for gangliosides and use thereof
GB201209584D0 (en) Modified antibodies
GB201208372D0 (en) Antibodies and uses thereof